Cibus ( NASDAQ:CBUS – Get Free Report ) is one of 404 publicly-traded companies in the 'Biotechnology' industry, but how does it contrast to its competitors? We will compare Cibus to related companies based on the strength of its dividends, analyst recommendations, valuation, risk, profitability, earnings and institutional ownership. Volatility & Risk Cibus has a beta of 1.91, meaning that its share price is 91% more volatile than the S&P 500. Comparatively, Cibus' competitors have a beta of 1.

https://www.dailypolitical.com/2023/09/04/contrasting-cibus-cbus-and-its-peers.html

#dailypolitical